Business Standard

Tuesday, January 14, 2025 | 02:47 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Purity norms drive nanotech in pharma

A big challenge that drug makers face is the high volume of chemicals which are used and then wasted during the manufacturing process

medicines, durgs, pharma, pharmaceuticals
Premium

In 2018-19, 973 brands were pulled out of the market, against 863 in 2017-18

Pranjal Sharma
In a shabby lane of Noida’s sector 2, a non-descript building houses the India offices of a clever little company.
 
Arcanely named i3 Nanotec, it has been using nanotechnology for Indian pharmaceutical majors. One of the big challenges that drug makers face is the high volume of chemicals which are used and then wasted during the manufacturing process. A long-standing challenge for the industry worldwide has been to reduce and recover the input chemicals. By recovering the chemicals, the environmental impact is minimised. But it makes business sense, too, since recovering and reusing the expensive chemicals helps slash input
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in